Azer Scientific Incorporated v. Quidel Corporation

District Court, E.D. Pennsylvania·Decided January 27, 2023·No. 5:21-cv-02972·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA __________________________________________

AZER SCIENTIFIC INCORPORATED, : Plaintiff, : : v. : Civil No. 5:21-cv-02972-JMG : QUIDEL CORPORATION, : Defendant. : __________________________________________

MEMORANDUM OPINION GALLAGHER, J. January 27, 2023 Plaintiff Azer Scientific Incorporated alleges Defendant Quidel Corporation breached a contractual agreement the Parties formed over email. On December 5, 2022, this Court found the Parties’ email correspondence on March 25, 2021 amounts to a binding contract. See generally Mem. Op., ECF No. 66 (granting partial summary judgment). On March 25, 2021, the Parties agreed Defendant Quidel would pay Plaintiff Azer to fill, cap, and manufacture reagent for 120 million two mL tubes over a period of twelve months at a price of $0.087975 per tube, for a total contract price of $10,557,000.00. Mem. Op., ECF No. 103 at 12 (outlining the Court’s understanding of the contract’s pricing). Azer now moves in limine for a ruling the Pennsylvania Uniform Commercial Code, Article 2, 13 Pa.C.S. § 2101 et seq. (U.C.C.) applies to the Parties’ March 25, 2021 contract. See generally Pl.’s Mot. in Lim., ECF No. 76 at 3. Quidel opposes Azer’s motion in limine. Quidel avers the U.C.C. does not apply to the Parties’ contract because the Parties’ contemplated a services contract based on Azer’s automated tube-filling services. Def.’s Resp. in Opp’n, ECF No. 86 at 3. The Court agrees the Parties’ contract is predominantly for the performance of services. For the following reasons, Azer’s Motion in Limine for a Ruling the U.C.C Applies to the the Parties’ Contract will be denied.

I. FACTUAL BACKGROUND Azer provides manual and automated tube-filling services, and manufactures and supplies products for laboratories. Pl.’s Am. Compl., ECF No. 10 ¶2. Quidel develops and manufactures medical devices. Id. On March 2, 2021, Azer approached Quidel to see if Quidel needed “any

other products.” Joint Appendix, ECF No. 48-4 at JA131. Azer pointed out its capacity to fill products because of “ [its] cleanroom with automation that [it] uses[s] to fill special liquids/media.” Id. Quidel responded it “ha[d] a need for filling.” Id. Quidel then asked about Azer’s “available filling capacity now.” Id. On March 4, 2021, Azer informed Quidel it could procure machines “to enable [Azer] to fill and cap over one (1) million 2mL tubes per week.” Id. at JA107. On March 15, 2021, Azer provided Quidel with a pricing proposal based on the length of

commitment; the pricing proposal listed, inter alia, the “[v]olume” of tubes per week, and the “[p]rice per fill.” Id. at JA118. On March 16, 2021, Quidel asked Azer to provide a new quote also including the price for Azer to manufacture the reagent solution to fill the tubes. Id. at JA101. Azer provided a quote with a price of $0.0808 per tube for filling services, and $0.007175 per tube to manufacture the reagent formulation. Id. at JA172. The Parties clarified Quidel would provide the tubes and caps to Azer, who would use equipment designed to work with the size of Quidel’s tubes and caps. Pl.’s Concise Statement of Undisputed Material Facts, ECF No. 48-2 ¶43 (quoting Joint Appendix, ECF No. 48-6 at JA945-46 (K. Bader Dep. Tr. 75:24 -76:18)).

On March 25, 2021, the Parties contracted for Azer to supply 120 million filled tubes over a period of twelve months. ECF No. 48-4 at JA181. At a rate of $0.087975 per tube, as agreed to by the Parties, the total contract price would equal $10,557,000.000—or, in other terms, $9,696,000.000 for the filling services and $861,000.000 for the reagent formulation. See ECF No. 103 at 12 (outlining the Court’s understanding of the contract’s pricing); see also ECF No. 48- 4 at JA172. The Parties continued to negotiate and draft additional forms to govern the agreement,

in the form of a “Purchase Order” and a “Supply Agreement.” See e.g., ECF No. 48-4 at JA187, JA197. But these forms were never executed.1 Azer filed a lawsuit on July 2, 2021 alleging Quidel breached the Parties’ March 25, 2021 contract, among other claims. See generally, Pl.’s Compl., ECF No. 1. On December 5, 2022, the Court resolved the Parties’ cross-motions for partial summary judgment. See generally, ECF No. 66; ECF No. 67. The Parties’ trial date is quickly approaching. In preparation of trial, Azer filed

a Motion in Limine for a Ruling the Pennsylvania U.C.C. governs the Parties’ March 25, 2021 because, it contends, the contract concerns goods—here, 120 million filled 2mL tubes. See generally ECF No. 80. Quidel opposes Azer’s motion. Quidel avers the U.C.C. does not apply to the Parties’ contract because the Parties’ contemplated a services contract based on Azer’s automated tube-filling services. ECF No. 86 at 3. II. LEGAL STANDARD

“By its terms, Article 2 of the U.C.C. only applies to contracts for the sale of goods.” Power Restoration Int'l, Inc. v. PepsiCo, Inc., No. CIV.A. 12-1922, 2015 WL 1208128, at *10 (E.D. Pa. Mar. 17, 2015). And “‘[g]oods’ are defined as ‘all things (including specially

1 The Parties agree a Supply Agreement—the governing document concerning their relationship and agreement—was never executed. Joint 26(f) Report, ECF No. 20 at 6; see also ECF No. 48- 4 at JA197. And Azer rejected Quidel’s draft Purchase Order. See ECF No. 48-2 ¶57; see also ECF No. 48-4 at JA197. manufactured goods) which are movable.’” Id. at *9 (internal citation omitted). Pennsylvania courts often “treat the question of whether goods or services predominate in a mixed goods and services contract as a . . . as a matter of law.” Id. (citing Cover v. Corle, 610 A.2d 1036 (Pa. Super. Ct. 1992)).

First, courts in Pennsylvania should “determine whether there is a ‘significant service component’” to the agreement. Id. at *10 (internal citation omitted). If there is no significant service component, the U.C.C. applies because the contract concerns the sale of goods. See id. “If there is a significant service component, then the second step of the analysis is to conduct the predominant factor test.” Id. (internal citation omitted).

“In the Third Circuit, courts determine the applicability of the UCC to a mixed contract for goods and service ‘by examining the predominance of goods or services . . . .’” Id. (quoting Advent Sys. Ltd. v. Unisys Corp., 925 F.2d 670, 676 (3d Cir. 1991) (applying Pennsylvania law)). So courts should “consider the purpose or essence of the contract.” Advent Sys. Ltd. 925 F.2d at 676. In doing so, “[c]ourts consider the totality of the circumstances, and their analyses . . . [include] (1) the relative costs of the materials supplied with the costs of the labor; (2) the compensation structure of the agreement; (3) the language and circumstances surrounding the contract; and (4)

the interrelationship of the goods and services to be provided (i.e., whether one is incidental to the other[sic].” Power Restoration, 2015 WL 1208128, at *10 (citing Advent Sys. Ltd. 925 F.2d at 676; KSM Assocs., Inc. v. ACS State Healthcare, LLC, No. 05–4118, 2006 WL 847786 (E.D. Pa. Mar. 30, 2006)). III. DISCUSSION

Free access — add to your briefcase to read the full text and ask questions with AI

Azer Scientific Incorporated v. Quidel Corporation, (E.D. Pa. 2023).

Azer Scientific Incorporated v. Quidel Corporation (Azer Scientific Incorporated v. Quidel Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

BMC Industries, Inc. v. Barth Industries, Inc.
160 F.3d 1322 (Eleventh Circuit, 1998)
Cober v. Corle
610 A.2d 1036 (Superior Court of Pennsylvania, 1992)
Meeker v. Hamilton Grain Elevator Co.
442 N.E.2d 921 (Appellate Court of Illinois, 1982)
BRUEL AND KJAER v. Village of Bensenville
969 N.E.2d 445 (Appellate Court of Illinois, 2012)